Grace Therapeutics GRCE
NASDAQ GRCE
$1.75 -0.06 (-3.31%)
At close: Nov 16, 2026 · 4:00 PM EST

Grace Therapeutics (GRCE) Net Income towards Common Stockholders (2011 - 2026)

Updated

Grace Therapeutics (GRCE) reported Net Income towards Common Stockholders of -$2.13 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), compared with -$938,000 a year earlier.

Analysis

Grace Therapeutics (GRCE) Net Income towards Common Stockholders (2011 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, Grace Therapeutics' Net Income towards Common Stockholders came in at -$21.41 million; for FY2026 (ended Mar 31, 2026), it was -$7.79 million.

  • By fiscal year, Net Income towards Common Stockholders came in at -$9.57 million in FY2025, -$12.85 million in FY2024, -$42.43 million in FY2023 and -$9.82 million in FY2022.
  • Five-year quarterly Net Income towards Common Stockholders spans a low of -$29.09 million in fiscal Q4 2023 and a high of $636,000 in fiscal Q4 2025.
  • Per Business Quant data, the three fiscal quarters before Q2 2027 came in at -$15.79 million (Q1 2027), -$1.18 million (Q4 2026) and -$2.32 million (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 6.45 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 210.00 Mn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 4.22 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 5.07 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 3.12 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 3.86 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 2.43 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 3.24 Bn
10 Grace Therapeutics 35.10 Mn -35.61 Mn - -2.13 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -2.13 Mn
Jun 30, 2026 -15.79 Mn
Mar 31, 2026 -1.18 Mn
Dec 31, 2025 -2.32 Mn
Sep 30, 2025 -938,000.00
Jun 30, 2025 -3.36 Mn
Mar 31, 2025 636,000.00
Dec 31, 2024 -4.16 Mn
Sep 30, 2024 -3.43 Mn
Jun 30, 2024 -2.62 Mn
Mar 31, 2024 -3.17 Mn
Dec 31, 2023 -2.39 Mn
Sep 30, 2023 -3.27 Mn
Jun 30, 2023 -4.02 Mn
Mar 31, 2023 -29.09 Mn
Dec 31, 2022 -3.89 Mn
Sep 30, 2022 -4.93 Mn
Jun 30, 2022 -4.52 Mn
Mar 31, 2022 -3.90 Mn
Dec 31, 2021 -3.78 Mn
API Access

Grace Therapeutics Net Income towards Common Stockholders API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=GRCE&period=max&api_key=YOUR_API_KEY